PhotoSCLART retweeted
2026 #NobelPrize laureate Henri Kagan discovered a new way of manipulating chemical reactions, allowing a greater excess of one of the mirror images to be created than was previously assumed possible. His discovery has been revolutionary for chemists who develop reactions for the manufacture of pharmaceuticals, flavours, scents and new materials.
Preliminarni raspored predavanja na PhotoSCLART radionici je gotov!
Ostalo je još manje od 2 nedelje do radionice 🗓
Preliminary timetable for the PhotoSCLART workshop is here. Less then two weeks left until the workshop.
#fondzanauku #photosclart #programprizma
#7005
🤖 Made with AI
Ostalo je još samo 10 dana za prijavu za PhotoSCLART radionicu.
Broj učesnika na radionici je ograničen i ostalo je malo slobodnih mesta.
Registracija za radionicu je obavezna.
Link za prijavu: docs.google.com/forms/d/e/1F…
#photosclart #fondzanauku #programprizma #7005
🤖 Made with AI
Na PhotoSCLART radionici "Novi pristupi u modernoj antikancer terapiji" moći ćete da saslušate pet raznolikih plenarnih predavanja koja pokrivaju različite aspekte razvoja biološki aktivnih jedinjenja.
🤖 Made with AI
Radionica će biti održana 2. oktobra 2026. godine u Palati nauke @palatanauke
Registracija za radionicu (link u opisu profila) je obavezna, a broj mesta je ograničen.
#fondzanauku #photosclart #prisma #programprizma @fondzanauku_rs
🤖 Made with AI
Sa zadovoljstvom Vas pozivamo na radionicu “Novel approaches in contemporary anticancer therapy,” koju organizujemo u okviru PhotoSCLART projekta.
Jednodnevna radionica će biti održana 2. oktobra 2026. godine u Sali Horizont u Palati nauke, u Beogradu.
Registracija za učešće na radionici je obavezna i broj mesta je ograničen.
Za radionicu se možete prijaviti putem linka ili skeniranjem QR koda sa slike.
Link za prijavu: docs.google.com/forms/d/e/1F…
PhotoSCLART retweeted
Check out this new review on artesunate in Pharmacological Research that is a product of a great collaboration with a team from Brno
sciencedirect.com/science/ar…
It was a pleasure to participate in Science Day and present our PhotoSCLArt project. We would like to thank SDIR for the invitation and the opportunity to engage with young science enthusiasts, visitors of all ages and researchers. #fondzanauku #photosclart #prisma
During the poster session at the 61st Meeting of the Serbian Chemical Society in Kragujevac, Ljiljana Koračak presented the latest research findings on the synthesis and anticancer activity of artesunate-pyrimidine derivatives.
#fondzanauku #photosclart #prisma
Dr. Ana Andrijević presented the latest results on the synthesis and anticancer activity of adamantane-sclareol hybrids targeting MDR non-small cell lung cancer during the poster session at the 61st Meeting of the Serbian Chemical Society.
#fondzanauku #photosclart #prisma
During the poster session at the 61st Meeting of the Serbian Chemical Society, Dr. Milica Selakovic presented the project results and received the IUPAC Best Poster Presentation Award.
Congratulations to Dr. Selakovic on this well deserved award! #fondzanauku #photosclart #prisma
As part of the oral session at the 61st Meeting of the Serbian Chemical Society, Dr. Andrea Nikolić presented an overview of the PhotoSCLART project and highlighted the key scientific results achieved during the first two years of the project. #fondzanauku #photosclart #prisma
Members of the PhotoSCLART project team, Ana Stepanović and Ema Lupšić, presented the latest findings of the project at the EACR 2026 Congress: “Innovative Cancer Science”, held in Budapest from June 8th to 11th, 2026. 🧬🧫
#fondzanauku #photosclart #prisma #eacr2026
Big congratulations to our team member Pavle Stojković on successfully defending his PhD thesis that focused on the synthesis and anticancer properties of sclareol derivatives. 🎓👨🏻🎓🧑🏻🔬 #fondzanauku #photosclart #prisma
PhotoSCLART retweeted
Na webinaru ćete moći da čujete najnovije rezultate ostvarene u sklopu projekta.
Registracija je obavezna. Možete se registrovati putem QR koda ili preko linka: docs.google.com/forms/d/e/1F….























